Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.750
+0.120 (7.36%)
At close: Jan 22, 2026, 4:00 PM EST
1.759
+0.009 (0.53%)
After-hours: Jan 22, 2026, 6:17 PM EST
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 124 employees as of September 30, 2025. The number of employees decreased by 83 or -40.10% compared to the same quarter last year.
Employees
124
Change
-83
Growth
-40.10%
Revenue / Employee
$249,298
Profits / Employee
-$715,629
Market Cap
65.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 124 | -83 | -40.10% |
| Jun 30, 2025 | 171 | -57 | -25.00% |
| Mar 31, 2025 | 176 | -61 | -25.74% |
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Sep 30, 2024 | 207 | -16 | -7.17% |
| Jun 30, 2024 | 228 | 28 | 14.00% |
| Mar 31, 2024 | 237 | 37 | 18.50% |
| Dec 31, 2023 | 236 | - | - |
| Sep 30, 2023 | 223 | - | - |
| Jun 30, 2023 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 195 |
| Acrivon Therapeutics | 78 |
| ImmuCell | 75 |
| InflaRx | 74 |
| PMV Pharmaceuticals | 47 |
| MiNK Therapeutics | 23 |
| CervoMed | 15 |
| Radiopharm Theranostics | 14 |
MGX News
- 10 days ago - Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - GlobeNewsWire
- 7 weeks ago - Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - GlobeNewsWire
- 2 months ago - Metagenomi to Present at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 2 months ago - Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce - Benzinga
- 2 months ago - Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates - GlobeNewsWire
- 2 months ago - Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development - GlobeNewsWire
- 3 months ago - Metagenomi taps Amazon's custom chips to develop gene-editing tools - Reuters
- 5 months ago - Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results - GlobeNewsWire